Impact of Mifepristone, a Glucocorticoid/Progesterone Antagonist, on HDL Cholesterol, HDL Particle Concentration, and HDL Function

CONTEXT: Mifepristone is a glucocorticoid and progestin antagonist under investigation for the treatment of Cushing's syndrome. Mifepristone decreases high-density lipoprotein (HDL) cholesterol (HDL-C) levels in treated patients, but the clinical significance of this is unclear because recent s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Page, Stephanie T., Krauss, Ronald M., Gross, Coleman, Ishida, Brian, Heinecke, Jay W., Tang, Chongren, Amory, John K., Schaefer, Peter M., Cox, Cheryl J., Kane, John, Purnell, Jonathan Q., Weinstein, Richard L., Vaisar, Tomáš
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2012
Assuntos:
Endocrine Care
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3339893/
https://ncbi.nlm.nih.gov/pubmed/22399518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2011-2813
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados